Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Gene Therapy On Cardiovascular Disease
1.2 Key Market Segments
1.2.1 Gene Therapy On Cardiovascular Disease Segment by Type
1.2.2 Gene Therapy On Cardiovascular Disease Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Gene Therapy On Cardiovascular Disease Market Overview
2.1 Global Market Overview
2.1.1 Global Gene Therapy On Cardiovascular Disease Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Gene Therapy On Cardiovascular Disease Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Gene Therapy On Cardiovascular Disease Market Competitive Landscape
3.1 Global Gene Therapy On Cardiovascular Disease Sales by Manufacturers (2019-2024)
3.2 Global Gene Therapy On Cardiovascular Disease Revenue Market Share by Manufacturers (2019-2024)
3.3 Gene Therapy On Cardiovascular Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Gene Therapy On Cardiovascular Disease Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Gene Therapy On Cardiovascular Disease Sales Sites, Area Served, Product Type
3.6 Gene Therapy On Cardiovascular Disease Market Competitive Situation and Trends
3.6.1 Gene Therapy On Cardiovascular Disease Market Concentration Rate
3.6.2 Global 5 and 10 Largest Gene Therapy On Cardiovascular Disease Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Gene Therapy On Cardiovascular Disease Industry Chain Analysis
4.1 Gene Therapy On Cardiovascular Disease Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Gene Therapy On Cardiovascular Disease Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Gene Therapy On Cardiovascular Disease Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gene Therapy On Cardiovascular Disease Sales Market Share by Type (2019-2024)
6.3 Global Gene Therapy On Cardiovascular Disease Market Size Market Share by Type (2019-2024)
6.4 Global Gene Therapy On Cardiovascular Disease Price by Type (2019-2024)
7 Gene Therapy On Cardiovascular Disease Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gene Therapy On Cardiovascular Disease Market Sales by Application (2019-2024)
7.3 Global Gene Therapy On Cardiovascular Disease Market Size (M USD) by Application (2019-2024)
7.4 Global Gene Therapy On Cardiovascular Disease Sales Growth Rate by Application (2019-2024)
8 Gene Therapy On Cardiovascular Disease Market Segmentation by Region
8.1 Global Gene Therapy On Cardiovascular Disease Sales by Region
8.1.1 Global Gene Therapy On Cardiovascular Disease Sales by Region
8.1.2 Global Gene Therapy On Cardiovascular Disease Sales Market Share by Region
8.2 North America
8.2.1 North America Gene Therapy On Cardiovascular Disease Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Gene Therapy On Cardiovascular Disease Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Gene Therapy On Cardiovascular Disease Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Gene Therapy On Cardiovascular Disease Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Gene Therapy On Cardiovascular Disease Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Biogen
9.1.1 Biogen Gene Therapy On Cardiovascular Disease Basic Information
9.1.2 Biogen Gene Therapy On Cardiovascular Disease Product Overview
9.1.3 Biogen Gene Therapy On Cardiovascular Disease Product Market Performance
9.1.4 Biogen Business Overview
9.1.5 Biogen Gene Therapy On Cardiovascular Disease SWOT Analysis
9.1.6 Biogen Recent Developments
9.2 Novartis
9.2.1 Novartis Gene Therapy On Cardiovascular Disease Basic Information
9.2.2 Novartis Gene Therapy On Cardiovascular Disease Product Overview
9.2.3 Novartis Gene Therapy On Cardiovascular Disease Product Market Performance
9.2.4 Novartis Business Overview
9.2.5 Novartis Gene Therapy On Cardiovascular Disease SWOT Analysis
9.2.6 Novartis Recent Developments
9.3 Gilead Sciences
9.3.1 Gilead Sciences Gene Therapy On Cardiovascular Disease Basic Information
9.3.2 Gilead Sciences Gene Therapy On Cardiovascular Disease Product Overview
9.3.3 Gilead Sciences Gene Therapy On Cardiovascular Disease Product Market Performance
9.3.4 Gilead Sciences Gene Therapy On Cardiovascular Disease SWOT Analysis
9.3.5 Gilead Sciences Business Overview
9.3.6 Gilead Sciences Recent Developments
9.4 Sarepta Therapeutics
9.4.1 Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Basic Information
9.4.2 Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Product Overview
9.4.3 Sarepta Therapeutics Gene Therapy On Cardiovascular Disease Product Market Performance
9.4.4 Sarepta Therapeutics Business Overview
9.4.5 Sarepta Therapeutics Recent Developments
9.5 Alnylam Pharmaceuticals
9.5.1 Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Basic Information
9.5.2 Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Product Overview
9.5.3 Alnylam Pharmaceuticals Gene Therapy On Cardiovascular Disease Product Market Performance
9.5.4 Alnylam Pharmaceuticals Business Overview
9.5.5 Alnylam Pharmaceuticals Recent Developments
9.6 Amgen
9.6.1 Amgen Gene Therapy On Cardiovascular Disease Basic Information
9.6.2 Amgen Gene Therapy On Cardiovascular Disease Product Overview
9.6.3 Amgen Gene Therapy On Cardiovascular Disease Product Market Performance
9.6.4 Amgen Business Overview
9.6.5 Amgen Recent Developments
9.7 Spark Therapeutics
9.7.1 Spark Therapeutics Gene Therapy On Cardiovascular Disease Basic Information
9.7.2 Spark Therapeutics Gene Therapy On Cardiovascular Disease Product Overview
9.7.3 Spark Therapeutics Gene Therapy On Cardiovascular Disease Product Market Performance
9.7.4 Spark Therapeutics Business Overview
9.7.5 Spark Therapeutics Recent Developments
9.8 Akcea Therapeutics
9.8.1 Akcea Therapeutics Gene Therapy On Cardiovascular Disease Basic Information
9.8.2 Akcea Therapeutics Gene Therapy On Cardiovascular Disease Product Overview
9.8.3 Akcea Therapeutics Gene Therapy On Cardiovascular Disease Product Market Performance
9.8.4 Akcea Therapeutics Business Overview
9.8.5 Akcea Therapeutics Recent Developments
9.9 bluebird bio
9.9.1 bluebird bio Gene Therapy On Cardiovascular Disease Basic Information
9.9.2 bluebird bio Gene Therapy On Cardiovascular Disease Product Overview
9.9.3 bluebird bio Gene Therapy On Cardiovascular Disease Product Market Performance
9.9.4 bluebird bio Business Overview
9.9.5 bluebird bio Recent Developments
9.10 Sunway Biotech
9.10.1 Sunway Biotech Gene Therapy On Cardiovascular Disease Basic Information
9.10.2 Sunway Biotech Gene Therapy On Cardiovascular Disease Product Overview
9.10.3 Sunway Biotech Gene Therapy On Cardiovascular Disease Product Market Performance
9.10.4 Sunway Biotech Business Overview
9.10.5 Sunway Biotech Recent Developments
9.11 SIBIONO
9.11.1 SIBIONO Gene Therapy On Cardiovascular Disease Basic Information
9.11.2 SIBIONO Gene Therapy On Cardiovascular Disease Product Overview
9.11.3 SIBIONO Gene Therapy On Cardiovascular Disease Product Market Performance
9.11.4 SIBIONO Business Overview
9.11.5 SIBIONO Recent Developments
9.12 AnGes
9.12.1 AnGes Gene Therapy On Cardiovascular Disease Basic Information
9.12.2 AnGes Gene Therapy On Cardiovascular Disease Product Overview
9.12.3 AnGes Gene Therapy On Cardiovascular Disease Product Market Performance
9.12.4 AnGes Business Overview
9.12.5 AnGes Recent Developments
9.13 Orchard Therapeutics
9.13.1 Orchard Therapeutics Gene Therapy On Cardiovascular Disease Basic Information
9.13.2 Orchard Therapeutics Gene Therapy On Cardiovascular Disease Product Overview
9.13.3 Orchard Therapeutics Gene Therapy On Cardiovascular Disease Product Market Performance
9.13.4 Orchard Therapeutics Business Overview
9.13.5 Orchard Therapeutics Recent Developments
9.14 Human Stem Cells Institute
9.14.1 Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Basic Information
9.14.2 Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Product Overview
9.14.3 Human Stem Cells Institute Gene Therapy On Cardiovascular Disease Product Market Performance
9.14.4 Human Stem Cells Institute Business Overview
9.14.5 Human Stem Cells Institute Recent Developments
10 Gene Therapy On Cardiovascular Disease Market Forecast by Region
10.1 Global Gene Therapy On Cardiovascular Disease Market Size Forecast
10.2 Global Gene Therapy On Cardiovascular Disease Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Gene Therapy On Cardiovascular Disease Market Size Forecast by Country
10.2.3 Asia Pacific Gene Therapy On Cardiovascular Disease Market Size Forecast by Region
10.2.4 South America Gene Therapy On Cardiovascular Disease Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Gene Therapy On Cardiovascular Disease by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Gene Therapy On Cardiovascular Disease Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Gene Therapy On Cardiovascular Disease by Type (2025-2030)
11.1.2 Global Gene Therapy On Cardiovascular Disease Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Gene Therapy On Cardiovascular Disease by Type (2025-2030)
11.2 Global Gene Therapy On Cardiovascular Disease Market Forecast by Application (2025-2030)
11.2.1 Global Gene Therapy On Cardiovascular Disease Sales (K Units) Forecast by Application
11.2.2 Global Gene Therapy On Cardiovascular Disease Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
